Skip to content

Yoga for Young Adults Affected by Cancer

Yoga for Young Adults Affected by Cancer: Exploring Implementation and Effectiveness of an Online Program

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05314803
Enrollment
500
Registered
2022-04-06
Start date
2021-09-01
Completion date
2028-12-01
Last updated
2022-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Young Adult Cancer, Young Adult Oncology

Brief summary

Yoga may enhance physical and psychological outcomes among young adults affected by cancer. Yet, yoga has rarely been studied in this population. We developed and piloted a yoga program, which is now ready for implementation and evaluation. This single-group, mixed-methods project will explore effectiveness and implementation of the yoga program.

Interventions

BEHAVIORALYoga

Participants receive the yoga program, which is delivered by a trained yoga instructor (completed at least a 200-hour yoga teacher training, Yoga Thrive Teacher Training Certification (or similar), and/or practical experience working with individuals affected by cancer). The first class of the week is comprised of 45 minutes of gentle, progressive, hatha-based yoga sequencing and postures with the last 15 minutes focused on guided behaviour change and mindfulness techniques that varies week-to-week, based on the participants in the class. The second class of the week is 60 minutes of gentle, yin-based yoga sequencing and postures with an element of opening and relaxing.

Sponsors

Canadian Cancer Society (CCS)
CollaboratorOTHER
Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
University of Calgary
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult aged 18 years or older; 2. Diagnosed with cancer between the ages of 18-39 years; 3. At any stage of their cancer experience (i.e., on- or off-treatment); 4. Able to safely engage in yoga, as assessed by completing the Get Active Questionnaire and obtaining medical clearance (if indicated). 5. Willing and able to complete informed consent, questionnaires, physical assessments, and an interview in English.

Exclusion criteria

1\. Previous enrolment in the study, to avoid contamination and/or ceiling effects.

Design outcomes

Primary

MeasureTime frameDescription
ReachThrough study completion, an average of 5 yearsThe number of people who participate, and reasons why or why not.

Secondary

MeasureTime frameDescription
Functional performanceBaseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)Change in sit-to-stand (number of repetitions in 30 seconds) (see 12).
AttendanceThrough study completion, an average of 5 yearsNumber of classes attended out of the number of classes offered by study staff.
AdherenceThrough study completion, an average of 5 yearsNumber of classes attended out of the number of classes offered by study staff.
Missing dataThrough study completion, an average of 5 yearsPercentage of missing data on quantitative measures and completion of qualitative interviews.
Barriers and facilitators to exercise participationBaseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)Change in Barrier Self-Efficacy Scale (1). Scale range 0-100; higher scores indicates less barriers to participation.
Physical activity levelsBaseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)Changes in Godin Leisure Time Scale (2). Individuals indicate how many times per week and how long per session they exercise at certain intensity (mild, moderate, high). Higher scores indicate higher levels of physical activity.
FatigueBaseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)Change in Functional Assessment of Chronic Illness Therapy - Fatigue Scale (3). Scale range 0-4; selected items are reverse scored; higher score indicate less fatigue.
CognitionBaseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)Changes in Functional Assessment of Cancer Therapy - Cognitive Scale (4). Scale range 1-4; some items are reversed scored; higher scores indicate less cognitive impairment.
General health-related quality of lifeBaseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)Change in EuroQual - 5Dimensions (EQ-5D) Scale (6). Scale range 1-5 with lower scores indicating greater quality of life; visual analogue scale range 0-100 with higher scores indicating greater quality of life.
General well-beingBaseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)Change in Functional Assessment of Cancer Therapy - General Scale (7). Scale range 0-4; selected items are reversed scored; higher scores indicate greater quality of life.
Cancer-related symptomsBaseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)Change in Edmonton Symptom Assessment Scale (5). Scale range 0-10; lower scores indicate fewer/less severe symptoms.
Self-compassionBaseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)Change in Self-Compassion Scale (9). Scale range 1-5; higher scores indicate greater self-compassion.
StressBaseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)Change in Perceived Stress Scale (10). Scale range 0-4; some items are reverse scored; higher scores indicate more perceived stress.
Group identificationPost-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)Change in Group Identification Scale (11). Scale range 1-7; higher scores indicate greater identification with the group.
BalanceBaseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)Change in one legged stance test (seconds) (see 12).
Shoulder range of motionBaseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)Change in active shoulder flexion range of motion (degrees) (see 12).
Lower extremity flexibilityBaseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)Change in sit-and-reach test (cm) (see 12).
Aerobic enduranceBaseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)Change in 2 minute step test (steps) results (see 12).
Adverse eventsThrough study completion, an average of 5 yearsAdverse events will be defined as any negative effect caused (or suspected to be caused by) the yoga program.
Time to implement and deliverThrough study completion, an average of 5 yearsTime and expertise to deliver the intervention and physical assessments will be tracked.
Yoga program fidelityThrough study completion, an average of 5 yearsFidelity of the physical activity program implementation will be assessed via randomly video-auditing a subset of classes.
MindfulnessBaseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)Change in Mindful Attention Awareness Scale (8). Scale range 1-6; higher scores indicate higher levels of dispositional mindfulness.

Countries

Canada

Contacts

Primary ContactS. Nicole Culos-Reed, PhD
nculosre@ucalgary.ca403-220-7540
Backup ContactAmanda Wurz, PhD
amanda.wurz@ufv.ca604-504-7441

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026